Camille L Bedrosian Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Camille L Bedrosian.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Camille L Bedrosian. Camille L Bedrosian is a VP, Chief Medical Officer in ARIAD PHARMACEUTICALS INC ($ARIA) and a EVP and Chief Medical Officer in Ultragenyx Pharmaceutical Inc. ($RARE) and a Director in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and a Director in Crinetics Pharmaceuticals, Inc. ($CRNX).
Address: C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE 02139 MA
Companies in which Camille L Bedrosian is an Insider
ARIAD PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Camille L Bedrosian: VP, Chief Medical Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 18 2007
$ARIA Market Capitalization: $4.64B
$ARIA Previous Close: $23.81
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Crinetics Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Camille L Bedrosian: Director
Holdings: 0 shares
Latest Transaction: Sep 03 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RHYTHM PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Camille L Bedrosian: Director
Holdings: 0 shares
Latest Transaction: Dec 11 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ultragenyx Pharmaceutical Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Camille L Bedrosian: EVP and Chief Medical Officer
Holdings: 38,775 shares
Current Value: $2,827,085
Latest Transaction: May 10 2021
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Camille L Bedrosian
Sentiment: All, ARIA, CRNX, RYTM, RARE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2021 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Sell | S | 113.67 | 364 | 41,376 | 38,775 | 39.1 K to 38.8 K (-0.93 %) |
| Apr 19 2021 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Option Exercise | M | 55.00 | 5,000 | 275,000 | 58,000 | |
| Apr 19 2021 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Sell | S | 109.09 | 5,000 | 545,450 | 39,139 | 44.1 K to 39.1 K (-11.33 %) |
| Apr 19 2021 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Buy | M | 55.00 | 5,000 | 275,000 | 44,139 | 39.1 K to 44.1 K (+12.77 %) |
| Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Option Exercise | A | 142.47 | 11,000 | 1,567,170 | 11,000 | |
| Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Sell | S | 138.18 | 4,543 | 627,752 | 39,139 | 43.7 K to 39.1 K (-10.40 %) |
| Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Grant | A | 0.00 | 4,636 | 0 | 43,682 | 39 K to 43.7 K (+11.87 %) |